Name: drug safety in clinical practice (en Inglés)
Price: 93440.00 CLP
Availability: InStock
Author: Folb, Peter I.
ISBN: 9783540128113

portada drug safety in clinical practice (en Inglés)

Formato

Libro Físico

Autor

Peter I. Folb

Editorial

Springer

Año

1983

Idioma

Inglés

N° páginas

196

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 1.1 cm

Peso

0.29 kg.

ISBN

3540128115

ISBN13

9783540128113

Categorías

Medicina clínica e interna
Farmacología
Farmacia y prescripción

drug safety in clinical practice (en Inglés)

Peter I. Folb (Autor) · Springer · Tapa Blanda

Libro Físico

$ 93.440

$ 155.740

Ahorras: $ 62.300

40% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 26 de Julio y el Lunes 05 de Agosto.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "drug safety in clinical practice (en Inglés)"

Drugs may cause disease, or they may aggravate the morbidity of the condition for which they are prescribed, and certain patients may for one or other reason be particularly liable to drug injury. The inextricable relationships between the toxic profiles of drugs, the natural history of the diseases for which they are given, and the adverse drug effects that may develop in the course of such diseases are of considerable interest. It is the study of these rather neglected aspects of pharmacology and therapeutics which has formed the basis of this book. An explanation is required of the approach and the style which have been followed. The monograph does not purport to be comprehensive. Only important drug groups which are commonly used in practice are considered. Emphasis has been placed on achieving maximum benefit and safety of the appropriate drugs in the management of common illnesses. When treatment fails, either ab initio or subsequent to an initial response, the risk-benefit relationship of drugs inevitably alters. For this reason the main factors responsible for treatment failure have been considered, with special attention to the possible contribution of or implications for drug therapy in such a situation. Finally, proposals have been put forward for improving the diagnosis and reporting of adverse drug effects. In order to be practical and, as far as possible, constructive it has been necessary for me to "take a position" on numerous issues.